138 related articles for article (PubMed ID: 32060405)
21. Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited
Prieto-Conde MI; Labrador J; Hermida G; Alonso S; Jiménez C; García-Álvarez M; Medina A; Balanzategui A; Alcoceba M; Sarasquete ME; Puig N; González V; Gutiérrez NC; García-Sanz R; González-Díaz M; Chillón MDC
Leuk Lymphoma; 2020 Jan; 61(1):181-184. PubMed ID: 31385734
[No Abstract] [Full Text] [Related]
22. [Allogeneic hematopoietic stem cell transplantation for Familial platelet disorder with a propensity for acute myeloid malignancies with Runx1 germline mutations: a case report and literature review].
Wang LL; Guan J; Cheng P; Zhang T; Cheng H; Zou L
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):517-520. PubMed ID: 35968597
[No Abstract] [Full Text] [Related]
23. Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.
Harada H; Harada Y; Kimura A
Curr Cancer Drug Targets; 2006 Sep; 6(6):553-65. PubMed ID: 17017876
[TBL] [Abstract][Full Text] [Related]
24. Germline RUNX1 translocation in familial platelet disorder with propensity to myeloid malignancies.
Sakurai M; Nannya Y; Yamazaki R; Yamaguchi K; Koda Y; Abe R; Yokoyama K; Ogawa S; Mori T
Ann Hematol; 2022 Jan; 101(1):237-239. PubMed ID: 33462643
[No Abstract] [Full Text] [Related]
25. Familial myelodysplasia and acute myeloid leukaemia--a review.
Owen C; Barnett M; Fitzgibbon J
Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
[TBL] [Abstract][Full Text] [Related]
26. Deletion of RUNX1 exons 1 and 2 associated with familial platelet disorder with propensity to acute myeloid leukemia.
Cavalcante de Andrade Silva M; Krepischi ACV; Kulikowski LD; Zanardo EA; Nardinelli L; Leal AM; Costa SS; Muto NH; Rocha V; Velloso EDRP
Cancer Genet; 2018 Apr; 222-223():32-37. PubMed ID: 29666006
[TBL] [Abstract][Full Text] [Related]
27. Concomitant germ-line RUNX1 and acquired ASXL1 mutations in a T-cell acute lymphoblastic leukemia.
Prebet T; Carbuccia N; Raslova H; Favier R; Rey J; Arnoulet C; Vey N; Vainchenker W; Birnbaum D; Mozziconacci MJ
Eur J Haematol; 2013 Sep; 91(3):277-279. PubMed ID: 23692290
[No Abstract] [Full Text] [Related]
28. Germline Predisposition to Hematolymphoid Neoplasia.
Weinberg OK; Kuo F; Calvo KR
Am J Clin Pathol; 2019 Aug; 152(3):258-276. PubMed ID: 31309983
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of RUNX1 Gene Mutation in Patients with Myelodysplastic Syndrome].
Cai XH; Chen MY; Chao HY; Jiang NK; Lu XZ; Han WM; Qin W; Jia ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):202-208. PubMed ID: 32027277
[TBL] [Abstract][Full Text] [Related]
30. Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome.
Harada H; Harada Y
Crit Rev Eukaryot Gene Expr; 2005; 15(3):183-96. PubMed ID: 16390315
[TBL] [Abstract][Full Text] [Related]
31. Myeloid neoplasms with germ line RUNX1 mutation.
Hayashi Y; Harada Y; Huang G; Harada H
Int J Hematol; 2017 Aug; 106(2):183-188. PubMed ID: 28534116
[TBL] [Abstract][Full Text] [Related]
32. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
[TBL] [Abstract][Full Text] [Related]
33. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
Keel SB; Scott A; Sanchez-Bonilla M; Ho PA; Gulsuner S; Pritchard CC; Abkowitz JL; King MC; Walsh T; Shimamura A
Haematologica; 2016 Nov; 101(11):1343-1350. PubMed ID: 27418648
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcomes and Co-Occurring Mutations in Patients with RUNX1-Mutated Acute Myeloid Leukemia.
Khan M; Cortes J; Kadia T; Naqvi K; Brandt M; Pierce S; Patel KP; Borthakur G; Ravandi F; Konopleva M; Kornblau S; Kantarjian H; Bhalla K; DiNardo CD
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933735
[TBL] [Abstract][Full Text] [Related]
35. AML1/RUNX1 gene point mutations in childhood myeloid malignancies.
Migas A; Savva N; Mishkova O; Aleinikova OV
Pediatr Blood Cancer; 2011 Oct; 57(4):583-7. PubMed ID: 21294243
[TBL] [Abstract][Full Text] [Related]
36. Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes.
Gelsi-Boyer V; Trouplin V; Adélaïde J; Aceto N; Remy V; Pinson S; Houdayer C; Arnoulet C; Sainty D; Bentires-Alj M; Olschwang S; Vey N; Mozziconacci MJ; Birnbaum D; Chaffanet M
BMC Cancer; 2008 Oct; 8():299. PubMed ID: 18925961
[TBL] [Abstract][Full Text] [Related]
37. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
Schlegelberger B; Heller PG
Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
[TBL] [Abstract][Full Text] [Related]
38. Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder.
Churpek JE; Garcia JS; Madzo J; Jackson SA; Onel K; Godley LA
Leuk Lymphoma; 2010 Oct; 51(10):1931-5. PubMed ID: 20846103
[No Abstract] [Full Text] [Related]
39. [Gene mutations in the diagnosis of MPN and MDS/MPN: current state].
Xiao Z
Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):385-6. PubMed ID: 24857204
[No Abstract] [Full Text] [Related]
40. Molecular phenotype and bleeding risks of an inherited platelet disorder in a family with a RUNX1 frameshift mutation.
Badin MS; Iyer JK; Chong M; Graf L; Rivard GE; Waye JS; Paterson AD; Pare G; Hayward CPM
Haemophilia; 2017 May; 23(3):e204-e213. PubMed ID: 28181366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
